460
Participants
Start Date
May 31, 1998
Primary Completion Date
January 31, 2005
Study Completion Date
January 31, 2005
Thioctic Acid
600mg tablet once daily 4 years double-blind treatment period
Placebo
1 tablet once daily 4 years double-blind treatment period
University Hospital, Hvidovre
University Hospital Utrecht Department of Internal Medicine, Utrecht
University Clinic for Diabetes, Endocrinology and Metabolic, Zagreb
University Clinic of Internal Medicine, Zagreb
Ney York Hospital Cornell Med Center, New York
University of Pittsburgh Medical Center, Pittsburgh
C.H.U.S. General Hospital, Santiago de Compostela
University Clinic, Malmo
Leonard R. Strelitz Diabetes Institutes, Norfolk
East Carolina University, School of Medicine, Greenville
Hospital Geriatrico Diabetological Service, Padua
´Diabetes Care Center, Birmingham
Hosptal of Parma Department of Medicine, Parma
Ohio State University Medical Center, Columbus
The Cleveland Clinic Foundation, Cleveland
Mayo Clinic Rochester, Rochester
Loyola University Medical Center, Maywood
University of Missouri Dept. of Neurology, Columbia
Creighton University Diabetes Center, Omaha
Dallas Diabetes & Endocrine Center, Dallas
Baylor College of Medicine, Houston
Policlinic University, Napoli
Mayo Clinic Arizona, Scottsdale
Lovelace Scientific Resources, Inc., Albuquerque
Medical Building, Long Beach
City of Hope National Medical Center, Duarte
UCSD Neuromuscular Research Program, San Diego
Diabetes Research Center, Tustin
Hospital Jean Verdler, Bondy
University of California, San Francisco
Beth Israel Medical Center, Boston
University of Michigan Medical Center, Ann Arbor
Health Partners Riverside Neurology Clinic, Minneapolis
University of Texas South Western Medical Center, Dallas
Diabetes & Glandular Disease Center, San Antonio
Hospital del Mar Department Neurophysiology, Barcelona
Hospital Clinico y Provincial, Barcelona
Manchester Royal Infirmary Department of Medicine, Manchester
Collaborators (1)
Clinquest, Inc.
INDUSTRY
Ergomed
INDUSTRY
Quintiles, Inc.
INDUSTRY
MEDA Pharma GmbH & Co. KG
INDUSTRY